Representative before the EPO

Employment test 51 - 200 employees
Company dna j a kemp
no operation time available
1127.31
Headquarter in London and 4 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Andrew Bentham has worked on the following 230 EPO patent applications which have been published in the last five years:

EP10773823

SUCROSE TRANSPORTER GENES FOR INCREASING PLANT SEED LIPIDS

IPC classification:
A01H 5/00, A01H 5/10, C07K 14/415, C12N 15/82
Applicant:
E. I. Du Pont de Nemours and Company
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP10803313

MAIZE EVENT DP-004114-3 AND METHODS FOR DETECTION THEREOF

IPC classification:
A01H 5/10, C07K 14/325, C12N 15/82
Applicant:
Pioneer Hi-Bred International Inc.
Applicant:
E. I. Du Pont de Nemours and Company
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP11701711

COMPOSITIONS AND METHODS FOR MINIMIZING NORNICOTINE SYNTHESIS IN TOBACCO

IPC classification:
A01H 5/12, C12N 15/53, C12N 15/82
Applicant:
North Carolina State University
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP11701602

HPPD-INHIBITOR HERBICIDE TOLERANCE

IPC classification:
A01H 5/00, C12N 15/11, C12Q 1/68
Agent:
Andrew Bentham, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP11751362

ULTRA-LOW TRYPSIN INHIBITOR SOYBEAN

IPC classification:
A01H 5/10
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP11753677

ACID PRODUCTION BY FERMENTATION

IPC classification:
C12P 7/56
Applicant:
Lanzatech New Zealand Limited
Agent:
Harrison Goddard Foote LLP
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP11726005

ANTIBODIES TO HUMAN GDF8

IPC classification:
A61K 39/395, A61P 3/00, A61P 21/00, C07K 16/22
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
Andrew Bentham, J A Kemp
Status:
The patent has been granted
EP11729215

PRODUCTION OF FERTILE XY FEMALE ANIMALS FROM XY ES CELLS

IPC classification:
A01K 67/027, C12N 9/02, C12N 15/873
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP11735738

STABILIZED FORMULATIONS CONTAINING ANTI-NGF ANTIBODIES

IPC classification:
A61K 39/395, C07K 16/22
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP11745899

COMPOSITIONS AND METHODS COMPRISING SEQUENCES HAVING HYDROXYPHENYLPYRUVATE DIOXYGENASE (HPPD) ACTIVITY

IPC classification:
A01H 5/00, A01H 5/10, C12N 9/02, C12N 15/82, C12Q 1/68, G01N 33/573
Agent:
Andrew Bentham, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12179273

Novel glyphosate-n-acetyltransferase (gat) genes

IPC classification:
A01H 5/00, C12N 9/10, C12N 15/54, C12N 15/82
Applicant:
E. I. Du Pont de Nemours and Company
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP11799820

ISOLATED POLYNUCLEOTIDES EXPRESSING OR MODULATING MICRORNAs OR TARGETS OF SAME, TRANSGENIC PLANTS COMPRISING SAME AND USES THEREOF IN IMPROVING NITROGEN USE EFFICIENCY, ABIOTIC STRESS TOLERANCE, BIOMASS, VIGOR OR YIELD OF A PLANT

IPC classification:
A01H 5/00, C12N 15/82
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP11775888

METHOD OF RAPIDLY PRODUCING VACCINES FOR ANIMALS

IPC classification:
A61K 39/12, A61K 39/135, A61K 39/145, C07K 14/01, C07K 14/08, C07K 14/09, C07K 14/11, C12N 15/86
Agent:
Andrew Bentham, J A Kemp
Agent:
Intervet International BV
Status:
GRANT OF PATENT INTENDED
EP11732894

INSULIN PREPARATION

IPC classification:
A61K 9/00, A61K 38/28, A61K 47/42, A61P 3/10
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP11839643

ROLE OF ADAM10 AND ITS RELEVANCE TO DISEASE AND THERAPEUTICS

IPC classification:
A61K 38/04
Applicant:
University of Chicago
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP10784933

BRASSICA GAT EVENT DP-073496-4 AND COMPOSITIONS AND METHODS FOR THE IDENTIFICATION AND/OR DETECTION THEREOF

IPC classification:
C12N 15/82
Applicant:
Pioneer Hi-Bred International Inc.
Applicant:
E. I. Du Pont de Nemours and Company
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP11834686

PRODUCTION OF BUTANOL FROM CARBON MONOXIDE BY A RECOMBINANT MICROORGANISM

IPC classification:
C07C 31/12, C12N 1/21, C12N 15/74, C12P 7/16, C12P 7/52, C12R 1/01, C12R 1/02, C12R 1/145
Applicant:
Lanzatech New Zealand Limited
Agent:
Andrew Bentham, J A Kemp
Status:
PATENT GRANTED
EP11849985

METHODS FOR TREATING DENTAL DISEASES, DISORDERS AND INJURIES

IPC classification:
A01N 63/00
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP11805727

VIRAL PROMOTER, TRUNCATIONS THEREOF, AND METHODS OF USE

IPC classification:
A01H 5/00, C12N 15/82
Applicant:
Pioneer Hi-Bred International Inc.
Applicant:
E. I. Du Pont de Nemours and Company
Agent:
Andrew Bentham, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12199188

Alteration of tobacco alkaloid content through modification of specific cytochrome P450 genes

IPC classification:
A01H 5/12, C12N 15/53, C12N 15/82, C12Q 1/68
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12737066

WOUND HEALING DEVICE AND METHOD

IPC classification:
A61K 31/74
Agent:
Andrew Bentham, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP12705721

SNX9 AS A NOVEL BIOMARKER FOR CHRONIC INFLAMMATION AND ASSOCIATED IMMUNOSUPPRESSION AND A NEW REGULATOR OF T CELL RECEPTOR EXPRESSION AND FUNCTION

IPC classification:
G01N 33/564, G01N 33/569, G01N 33/574
Applicant:
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
Agent:
Andrew Bentham, J A Kemp
Agent:
Andrea Fleuchaus, Fleuchaus & Gallo Partnerschaft mbB
Status:
EXAMINATION IN PROGRESS
EP12705575

ROOT-PREFERRED PROMOTER AND METHODS OF USE

IPC classification:
A01H 5/00, C07K 14/415, C12N 15/82
Applicant:
Pioneer Hi-Bred International Inc.
Agent:
Andrew Bentham, J A Kemp
Status:
The patent has been granted
EP11764071

ANTI-CD48 ANTIBODIES AND USES THEREOF

IPC classification:
C07K 16/28
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
Pronovem
Agent:
Andrew Bentham, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP12709481

NOVEL BACILLUS THURINGIENSIS GENE WITH LEPIDOPTERAN ACTIVITY

IPC classification:
A01N 63/00, C07K 14/325, C12N 15/82
Applicant:
Pioneer Hi-Bred International Inc.
Agent:
Andrew Bentham, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP11766582

COMPOSITIONS AND METHODS RELATED TO PROTEIN A (SpA) ANTIBODIES AS AN ENHANCER OF IMMUNE RESPONSE

IPC classification:
A61K 39/085, C07K 16/12
Applicant:
University of Chicago
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12760610

CHANGES IN THE EXPRESSION OF MIR-200C/141 CLUSTER OF MICRORNAS AS BIOMARKERS FOR EPITHELIAL-TO-MESENCHYMAL TRANSITION IN HUMAN COLORECTAL CANCER METASTASIS

IPC classification:
C12Q 1/68
Applicant:
Baylor Research Institute
Agent:
Multiple attorneys, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12761204

BIOMARKERS FOR PREDICTING THE RECURRENCE OF COLORECTAL CANCER METASTASIS

IPC classification:
C12Q 1/68
Applicant:
Baylor Research Institute
Agent:
Multiple attorneys, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13759967

COMPOSITIONS AND METHODS FOR IDENTIFYING AND COMPARING MEMBERS OF MICROBIAL COMMUNITIES BY COMPUTATIONAL ANALYSIS OF AMPLICON SEQUENCES

IPC classification:
C12N 1/20, C12Q 1/04, C12Q 1/68, G06F 17/00
Agent:
Jennifer Atkinson, Barker Brettell LLP
Agent:
Andrew Bentham, J A Kemp
Status:
PATENT GRANTED
EP12767723

REVERSING THE EFFECTS OF THE TUMOR MICROENVIRONMENT USING CHIMERIC CYTOKINE RECEPTORS

IPC classification:
C12N 5/00
Applicant:
Baylor College of Medicine
Agent:
Multiple attorneys, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP12715300

SELF-REPRODUCING HYBRID PLANTS

IPC classification:
A01H 1/02, A01H 1/08, C07K 14/415, C12N 15/82
Applicant:
Pioneer Hi-Bred International Inc.
Agent:
Andrew Bentham, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11785543

HUMAN ANTIBODIES TO HUMAN TNF-LIKE LIGAND 1A (TL1A)

IPC classification:
C07K 16/28
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
Pronovem
Agent:
Andrew Bentham, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP12720059

BACTERIAL MRNA SCREEN STRATEGY FOR NOVEL PESTICIDE-ENCODING NUCLEIC ACID MOLECULE DISCOVERY

IPC classification:
C12N 15/82
Applicant:
Pioneer Hi-Bred International Inc.
Agent:
Andrew Bentham, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12726895

COMBINATIONS OF ANTI ErbB ANTIBODIES FOR THE TREATMENT OF CANCER

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/28, C07K 16/32
Applicant:
Yeda Research and Development Co. Ltd.
Agent:
Dennemeyer SA
Agent:
Andrew Bentham, J A Kemp
Agent:
Cabinet Regimbeau
Status:
GRANT OF PATENT INTENDED
EP12722043

CHLOROPLAST TRANSIT PEPTIDES AND METHODS OF THEIR USE

IPC classification:
A01H 5/00, C07K 14/415, C12N 15/82
Applicant:
E. I. Du Pont de Nemours and Company
Agent:
Andrew Bentham, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12727767

ANTI-ANGPTL3 ANTIBODIES AND USES THEREOF

IPC classification:
A61K 39/395, A61P 3/06, C07K 16/22
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
Andrew Bentham, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP11824106

IMMUNOTHERAPY OF CANCER USING GENETICALLY ENGINEERED GD2-SPECIFIC T CELLS

IPC classification:
A61K 39/00, C07K 16/18, C12N 5/0783
Applicant:
Baylor College of Medicine
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12741436

METHODS AND COMPOSITIONS FOR TARGETED INTEGRATION IN A PLANT

IPC classification:
A01H 5/00, C12N 15/82
Applicant:
Pioneer Hi-Bred International Inc.
Applicant:
E. I. Du Pont de Nemours and Company
Agent:
Andrew Bentham, J A Kemp
Status:
APPLICATION WITHDRAWN
EP11805668

THE STRUGGLE AGAINST DESERTIFICATION

IPC classification:
E02B 3/00, E02B 13/00
Agent:
Andrew Bentham, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12753873

ANTI-TIE2 ANTIBODIES USES THEREOF

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/28
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
Andrew Bentham, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP11748700

TREATMENT

IPC classification:
A61K 31/00, A61K 31/417, A61K 31/4178, A61K 31/475, A61P 1/16
Applicant:
UCL Business plc
Agent:
Multiple attorneys, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12772516

PROGNOSTIC METHODS AND COMPOSITIONS FOR PREDICTING INTERFERON TREATMENT EFICACY IN A SUBJECT

IPC classification:
C12Q 1/68
Applicant:
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
Agent:
Andrew Bentham, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12832589

MEDIA SUPPLEMENTS AND METHODS TO CULTURE HUMAN GASTROINTESTINAL ANAEROBIC MICROORGANISMS

IPC classification:
C12N 1/20
Applicant:
University of Guelph
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12761864

METHODS FOR REDUCING LIPOPROTEIN(a) LEVELS BY ADMINISTERING AN INHIBITOR OF PROPROTEIN CONVERTASE SUBTILISIN KEXIN-9 (PCSK9)

IPC classification:
A61P 3/06, C07K 16/40
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
Andrew Bentham, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP12834178

THE INTRODUCTION OF MODULAR VECTOR ELEMENTS DURING PRODUCTION OF A LENTIVIRUS

IPC classification:
C12N 15/00, C12N 15/87
Applicant:
GE Healthcare Dharmacon Inc
Agent:
Andrew Bentham, J A Kemp
Status:
PATENT GRANTED
EP12734721

METHODS FOR ACCELERATING THE HEALING OF CONNECTIVE TISSUE INJURIES AND DISORDERS

IPC classification:
A61K 35/12, A61K 35/50, A61K 38/19, A61P 19/00
Agent:
Andrew Bentham, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP12839041

OPTIMIZATION OF VECTORS FOR EFFECTIVE DELIVERY AND EXPRESSION OF GENETIC CONTENT

IPC classification:
C12N 15/00, C12N 15/113, C12Q 1/68
Applicant:
GE Healthcare Dharmacon Inc
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP10835157

METHOD FOR INCORPORATING INTERNAL POLAR AND IONIZABLE GROUPS IN PROTEINS

IPC classification:
C07K 14/31, C12N 9/22, G01N 33/53
Applicant:
Johns Hopkins University
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14163635

Method for generating an non-human animal homozygous for a genetic modification

IPC classification:
A01K 67/027, C07K 14/47, C12N 5/073, C12N 15/85, C12N 15/87
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
Andrew Bentham, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP12778014

METHODS FOR IMPROVING SEED PRODUCTION IN MAIZE

IPC classification:
A01C 1/00, A01G 7/00, A01H 5/10
Applicant:
Pioneer Hi-Bred International Inc.
Agent:
Andrew Bentham, J A Kemp
Status:
PATENT GRANTED
EP12842179

METHOD TO MEASURE INFLAMMATION IN THE CONJUNCTIVA OF PATIENTS WITH TEAR DYSFUNCTION

IPC classification:
C12N 5/00
Applicant:
Baylor College of Medicine
Agent:
Andrew Bentham, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12787991

MIRNAS AS DIAGNOSTIC BIOMARKERS TO DISTINGUISH BENIGN FROM MALIGNANT THYROID TUMORS

IPC classification:
C12Q 1/68
Agent:
Andrew Bentham, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12795906

IMPROVING PLANT DROUGHT TOLERANCE, NITROGEN USE EFFICIENCY AND YIELD

IPC classification:
C07K 14/415, C12N 15/82
Applicant:
Pioneer Hi-Bred International Inc.
Agent:
Andrew Bentham, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12846950

FIBROBLASTS FOR TREATMENT OF DEGENERATIVE DISC DISEASE

IPC classification:
C12N 5/00
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14160580

Method for producing a euphorbia interspecific hybrid plant with red bracts and non-functional small cyathia

IPC classification:
A01H 1/08, A01H 4/00, A01H 5/02
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION REQUESTED
EP12791657

COMPOSITIONS AND METHODS FOR INCREASING MUSCLE MASS AND MUSCLE STRENGTH BY SPECIFICALLY ANTAGONIZING GDF8 AND/OR ACTIVIN A

IPC classification:
A61K 39/395, A61P 21/06, C07K 16/22
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14163642

Use of rodent to produce hybrid antibodies containing human variable region and rodent constant or FC region

IPC classification:
A01K 67/027, C07K 16/00, C07K 16/28, C07K 16/46, C12N 5/00, C12N 5/16, C12N 15/00, C12N 15/09, C12N 15/63, C12N 15/67, C12N 15/74, C12N 15/85, C12N 15/90, C12P 21/00, C12P 21/04, C12P 21/06
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12853200

A CTC BIOMARKER ASSAY TO COMBAT BREAST CANCER BRAIN METASTASIS

IPC classification:
A61P 35/00, A61P 35/04, C12Q 1/68, G01N 33/53
Applicant:
Baylor College of Medicine
Agent:
Multiple attorneys, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14172420

Rodent capable of producing hybrid antibodies containing human variable regions and rodent constant regions

IPC classification:
C12N 5/00, C12N 5/02, C12N 5/16, C12N 15/00, C12N 15/09, C12N 15/63, C12N 15/74, C12P 21/04, C12P 21/06
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
Andrew Bentham, J A Kemp
Status:
PATENT GRANTED
EP11831546

METHODS OF MAKING L-ORNITHINE PHENYL ACETATE

IPC classification:
A61K 31/192, A61K 31/198, A61P 1/16, C07C 57/46, C07C 227/18, C07C 229/26
Agent:
Multiple attorneys, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP12851407

MUTATIONS OF HISTONE PROTEINS ASSOCIATED WITH PROLIFERATIVE DISORDERS

IPC classification:
A61K 38/17, A61P 35/00, C07K 14/47, C07K 16/18, C12N 15/12, C12Q 1/00, G01N 33/574, G01N 33/68
Applicant:
Universitätsklinikum Heidelberg
Applicant:
McGill University - The Royal Institution for the Advancement of Learning
Agent:
Andrew Bentham, J A Kemp
Status:
PATENT GRANTED
EP12857876

GENE TARGETING VECTOR, AND METHOD FOR USING SAME

IPC classification:
C12N 1/15, C12N 1/19, C12N 1/21, C12N 5/10, C12N 15/09
Applicant:
Yokohama City University
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12809955

HUMANIZED LIGHT CHAIN MICE

IPC classification:
A01K 67/027, C07K 16/46, C12N 9/64
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
Andrew Bentham, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP12859326

IDENTIFICATION OF METASTASIS-SPECIFIC MIRNA AND HYPOMETHYLATION SIGNATURES IN HUMAN COLORECTAL CANCER

IPC classification:
C12Q 1/68
Applicant:
Baylor Research Institute
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12717029

DOWN-REGULATION OF A HOMEODOMAIN-LEUCINE ZIPPER I-CLASS HOMEOBOX GENE FOR IMPROVED PLANT PERFORMANCE

IPC classification:
C07K 14/415, C12N 15/82
Applicant:
Pioneer Hi-Bred International Inc.
Agent:
Andrew Bentham, J A Kemp
Status:
APPLICATION WITHDRAWN
EP12715298

COMPOSITIONS AND METHODS FOR THE EXPRESSION OF A SEQUENCE IN A REPRODUCTIVE TISSUE OF A PLANT

IPC classification:
C07K 14/415, C12N 15/82
Applicant:
Pioneer Hi-Bred International Inc.
Agent:
Andrew Bentham, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12716935

OVULE SPECIFIC PROMOTER AND METHODS OF USE

IPC classification:
A01H 5/00, C12N 15/82
Applicant:
Pioneer Hi-Bred International Inc.
Agent:
Andrew Bentham, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12715292

A METHOD TO SCREEN PLANTS FOR GENETIC ELEMENTS INDUCING PARTHENOGENESIS IN PLANTS

IPC classification:
C12N 15/82
Applicant:
Pioneer Hi-Bred International Inc.
Agent:
Andrew Bentham, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP12716933

METHODS AND COMPOSITIONS FOR MODULATING EXPRESSION OR ACTIVITY OF A RKD POLYPEPTIDE IN A PLANT

IPC classification:
C07K 14/415, C12N 15/82
Applicant:
Pioneer Hi-Bred International Inc.
Agent:
Andrew Bentham, J A Kemp
Status:
APPLICATION WITHDRAWN
EP12716930

SOMATIC OVULE SPECIFIC PROMOTER AND METHODS OF USE

IPC classification:
A01H 5/00, C12N 5/10, C12N 15/82
Applicant:
Pioneer Hi-Bred International Inc.
Agent:
Andrew Bentham, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13705840

SYNTHETIC PEPTIDES FOR TREATMENT OF BACTERIAL INFECTIONS

IPC classification:
A61K 38/08, A61K 38/17, A61P 31/04
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13701868

METHOD FOR OBTAINING MAB-LIKE CELLS AND USES THEREOF

IPC classification:
C12N 5/073
Applicant:
UCL Business plc
Agent:
Andrew Bentham, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13702566

METHODS AND COMPOSITIONS FOR GENERATING COMPLEX TRAIT LOCI

IPC classification:
C12N 9/22, C12N 15/82
Applicant:
Pioneer Hi-Bred International Inc.
Applicant:
E. I. Du Pont de Nemours and Company
Agent:
Andrew Bentham, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13702556

STABILIZED FORMULATIONS CONTAINING ANTI-ANG2 ANTIBODIES

IPC classification:
A61K 39/395, A61K 47/06, A61K 47/26, C07K 16/22
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12791608

METHODS AND COMPOSITIONS FOR PREPARING SAMPLES FOR IMMUNOSTAINING

IPC classification:
A61L 27/36, A61L 27/60, G01N 1/28
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13702876

ANTI-ASIC1 ANTIBODIES AND USES THEREOF

IPC classification:
A61K 39/395, A61P 29/00, C07K 16/18
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13746524

PEPMIXES TO GENERATE MULTIVIRAL CTLS WITH BROAD SPECIFICITY

IPC classification:
A01N 63/00, C12N 15/00
Applicant:
Baylor College of Medicine
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12853926

HOMOMULTIVALENT AND HETEROMULTIVALENT INHIBITORS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PMSA) AND USES THEREOF

IPC classification:
A61K 31/4196, A61P 35/00, C07D 403/12, C07D 403/14
Applicant:
Johns Hopkins University
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14173970

Compositions for the treatment of systemic onset juvenile idiopathic arthritis

IPC classification:
A61K 38/20, A61P 19/00, A61P 29/00, C07K 16/24
Applicant:
Baylor Research Institute
Agent:
Andrew Bentham, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12817886

DENDRITIC CELL (DC)-VACCINE THERAPY FOR PANCREATIC CANCER

IPC classification:
A61K 39/00, A61K 45/06, A61P 35/00, C12N 5/0784
Applicant:
Baylor Research Institute
Agent:
Andrew Bentham, J A Kemp
Status:
APPLICATION WITHDRAWN
EP13707524

ANTI-BIG-ENDOTHELIN-1 (BIG-ET-1) ANTIBODIES AND USES THEREOF

IPC classification:
C07K 16/26
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13708639

METHODS FOR THE TREATMENT OF B CELL-MEDIATED INFLAMMATORY DISEASES

IPC classification:
A61P 37/00, C07K 16/24
Agent:
Andrew Bentham, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13708641

HUMAN ANTIBODIES TO CLOSTRIDIUM DIFFICILE TOXINS

IPC classification:
A61K 39/40, A61P 31/04, C07K 16/12
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13709521

TREATMENT OF CANCER

IPC classification:
A61K 38/17, A61P 35/00
Applicant:
UCL Business plc
Agent:
Andrew Bentham, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP12752319

COMPUTERIZED TOOL PATH GENERATION

IPC classification:
G05B 19/4093, G06F 19/00
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13711546

GENETIC REDUCTION OF MALE FERTILITY IN PLANTS

IPC classification:
C07K 14/415, C12N 15/82
Applicant:
Pioneer Hi-Bred International Inc.
Applicant:
E. I. Du Pont de Nemours and Company
Agent:
Andrew Bentham, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13761946

SUPPRESSOR CELL FUNCTION INHIBITION FOLLOWING LISTERIA VACCINE TREATMENT

IPC classification:
A61K 39/00, A61K 39/02
Agent:
Pearl Cohen Zedek Latzer Baratz UK LLP
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13760865

CITRULLINATED BRAIN AND NEUROLOGICAL PROTEINS AS BIOMARKERS OF BRAIN INJURY OR NEURODEGENERATION

IPC classification:
G01N 33/48, G01N 33/50, G01N 33/68
Applicant:
Johns Hopkins University
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13713036

MICE THAT PRODUCE ANTIGEN-BINDING PROTEINS WITH PH-DEPENDENT BINDING CHARACTERISTICS

IPC classification:
A01K 67/027, C07K 16/00, C12N 15/85
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13712987

MULTISPECIFIC ANTIGEN-BINDING MOLECULES AND USES THEREOF

IPC classification:
C07K 14/705, C07K 16/28
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13712633

GENETIC REDUCTION OF MALE FERTILITY IN PLANTS

IPC classification:
C07K 14/415, C12N 15/82
Applicant:
Pioneer Hi-Bred International Inc.
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13714127

NON-HUMAN ANIMALS EXPRESSING PH-SENSITIVE IMMUNOGLOBULIN SEQUENCES

IPC classification:
A01K 67/027, C07K 16/00, C12N 15/85
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13711116

POROUS CARBON PARTICLES FOR USE IN THE TREATMENT OR PREVENTION OF LIVER DISEASE

IPC classification:
A61K 9/16, A61K 33/44
Applicant:
UCL Business plc
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13713652

HISTIDINE ENGINEERED LIGHT CHAIN ANTIBODIES AND GENETICALLY MODIFIED NON-HUMAN ANIMALS FOR GENERATING THE SAME

IPC classification:
A01K 67/027, C07K 16/00, C12N 15/85
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13764672

HERBICIDE TOLERANT SOYBEANS AND METHODS OF USE

IPC classification:
A01H 1/06, A01H 5/00, C12N 5/04, C12N 15/82
Applicant:
Pioneer Hi-Bred International Inc.
Applicant:
E. I. Du Pont de Nemours and Company
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13715578

MAIZE EVENT DP-004114-3 AND METHODS FOR DETECTION THEREOF

IPC classification:
C12N 15/82, C12Q 1/68
Applicant:
Pioneer Hi-Bred International Inc.
Applicant:
E. I. Du Pont de Nemours and Company
Agent:
Andrew Bentham, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13767441

INTEGRATED ENDOSCOPE IRRIGATION

IPC classification:
A61B 1/00, A61B 17/00, A61M 25/00, F16L 1/00
Agent:
Andrew Bentham, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13711113

TREATMENT OF ACUTE INFLAMMATION IN THE RESPIRATORY TRACT

IPC classification:
A61K 31/443, A61K 39/395, C07K 16/28
Applicant:
UCL Business plc
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13772074

ENZYME-ALTERED METABOLITE ACTIVITY

IPC classification:
C12N 9/02, C12N 15/53, C12N 15/74, C12P 7/04
Applicant:
Lanzatech New Zealand Limited
Agent:
Andrew Bentham, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13718744

METHODS FOR TREATING OR PREVENTING INFLUENZA VIRUS INFECTION BY ADMINISTERING A SERINE PROTEASE INHIBITOR

IPC classification:
A61K 39/395, A61P 31/16
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
Andrew Bentham, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP12732315

METHOD AND SYSTEM FOR SUSPENSION CELL CULTURE

IPC classification:
C12N 5/02
Agent:
Andrew Bentham, J A Kemp
Status:
APPLICATION WITHDRAWN
EP13721544

HUMAN ANTIBODIES TO FEL D1 AND METHODS OF USE THEREOF

IPC classification:
A61K 39/35, A61P 37/08, C07K 16/18
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION REQUESTED
EP13720718

NUCLEASE-MEDIATED TARGETING WITH LARGE TARGETING VECTORS

IPC classification:
C07K 14/715, C12N 15/85, C12N 15/90
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
Anton Hutter, Venner Shipley LLP
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14190388

Dual delivery system for heterologous antigens

IPC classification:
A61K 39/02, A61P 35/00
Agent:
Pearl Cohen Zedek Latzer Baratz UK LLP
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13793326

SELECTION METHOD AND RECOMBINANT MICROORGANISMS AND USES THEREFOR

IPC classification:
C12N 1/21, C12N 15/63, C12N 15/74, C12P 3/00
Applicant:
Lanzatech New Zealand Limited
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13171892

Yield enhancement in plants by modulation of AP2 transcription factor

IPC classification:
C07K 14/415, C12N 15/82
Applicant:
Pioneer Hi-Bred International Inc.
Agent:
Andrew Bentham, J A Kemp
Status:
APPLICATION WITHDRAWN
EP13730702

STABILIZED FORMULATIONS CONTAINING ANTI-DLL4 ANTIBODIES

IPC classification:
A61K 39/395
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13797085

RECOMBINANT MICROORGANISMS AND USES THEREFOR

IPC classification:
C12N 1/21, C12N 15/53, C12N 15/63, C12N 15/74, C12P 7/62
Applicant:
Lanzatech New Zealand Limited
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13797982

RECOMBINANT MICROORGANISMS AND USES THEREFOR

IPC classification:
C12N 1/21, C12N 15/52, C12N 15/63, C12N 15/74, C12P 5/02
Applicant:
Lanzatech New Zealand Limited
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13710268

HUMANIZED NON-HUMAN ANIMALS WITH RESTRICTED IMMUNOGLOBULIN HEAVY CHAIN LOCI

IPC classification:
A01K 67/027, C07K 16/28, C07K 16/40, C07K 16/46
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14195502

Humanized IL-7 rodents

IPC classification:
A01K 67/027, C07K 14/54
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
Andrew Bentham, J A Kemp
Status:
PATENT GRANTED
EP13780236

YEAST-CONTAINING SILAGE INOCULANTS FOR THE ENHANCEMENT OF SILAGE DIGESTION AND FERMENTATION IN THE RUMEN

IPC classification:
A23K 1/00, A23K 1/18, A23K 3/00, A23K 3/03
Applicant:
Pioneer Hi-Bred International Inc.
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13800454

RECOMBINANT MICROORGANISMS AND USES THEREFOR

IPC classification:
C12N 1/21, C12N 15/53, C12N 15/60, C12N 15/63, C12P 7/16
Applicant:
Lanzatech New Zealand Limited
Agent:
Andrew Bentham, J A Kemp
Status:
PATENT GRANTED
EP13739875

HUMANIZED IL-7 RODENTS

IPC classification:
A01K 67/027, C07K 14/54
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13732736

SEPARABLY-DRIVEN ROTOR PORTIONS AND ASSOCIATED METHOD FOR THRESHING GRAIN

IPC classification:
A01F 7/06
Applicant:
Pioneer Hi-Bred International Inc.
Agent:
Andrew Bentham, J A Kemp
Status:
PATENT GRANTED
EP13806177

RECOMBINANT MICROORGANISMS MAKE BIODIESEL

IPC classification:
C12N 1/21, C12N 15/52, C12P 7/64
Applicant:
Lanzatech New Zealand Limited
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13733524

MANIPULATION OF SERINE/THREONINE PROTEIN PHOSPHATASES FOR CROP IMPROVEMENT

IPC classification:
A01H 1/04, C12N 9/16, C12N 15/82, C12Q 1/68
Applicant:
Pioneer Hi-Bred International Inc.
Agent:
Andrew Bentham, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13812578

APPARATUS AND METHOD FOR DETECTING MYOCARDIAL ISCHEMIA USING ANALYSIS OF HIGH FREQUENCY COMPONENTS OF AN ELECTROCARDIOGRAM

IPC classification:
A61B 5/04, A61B 5/0452
Agent:
Andrew Bentham, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13828037

THERAPEUTICS DISPENSING DEVICE AND METHODS OF MAKING SAME

IPC classification:
A61P 27/06
Applicant:
The Regents of the University of California
Agent:
Multiple attorneys, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP15151655

Histidine engineered light chain antibodies and genetically modified non-human animals for generating the same

IPC classification:
A01K 67/027, C07K 16/00, C12N 15/85
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13751027

ANTI-PCSK9 ANTIBODIES WITH PH-DEPENDENT BINDING CHARACTERISTICS

IPC classification:
A61K 39/395, A61P 3/06, C07K 16/40
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
Andrew Bentham, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13829465

NOVEL CELL COMPOSITIONS AND METHODS

IPC classification:
A61K 45/00
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13753402

HUMAN ANTIBODIES TO GFR 3 AND METHODS OF USE THEREOF

IPC classification:
A61K 39/395, A61P 29/00, C07K 16/28
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13833516

RECOMBINANT MICROORGANISMS AND USES THEREFOR

IPC classification:
C12N 1/21, C12P 5/00, C12P 7/54
Applicant:
Lanzatech New Zealand Limited
Agent:
Andrew Bentham, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13759648

METHODS TO DIFFERENTIATE AND IMPROVE GERMPLASM FOR SEED EMERGENCE UNDER STRESS

IPC classification:
A01C 1/00, A01C 1/02
Applicant:
Pioneer Hi-Bred International Inc.
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP11820236

PROCESS FOR PRODUCING ETHANOL AND ETHYLENE VIA FERMENTATION

IPC classification:
C12P 7/06, C12R 1/145
Applicant:
Lanzatech New Zealand Limited
Agent:
Andrew Bentham, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13765844

METHODS FOR TREATING ATOPIC DERMATITIS BY ADMINISTERING AN IL-4R ANTAGONIST

IPC classification:
A61P 17/00, C07K 16/28, G01N 33/53
Applicant:
Regeneron Pharmaceuticals Inc
Applicant:
Sanofi, S.A.
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13835251

HIV VACCINE COMPOSITIONS AND METHODS

IPC classification:
A61K 39/395, A61P 31/00, A61P 31/18
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Baylor Research Institute
Agent:
Andrew Bentham, J A Kemp
Status:
APPLICATION WITHDRAWN
EP13773476

ANTI-CD3 ANTIBODIES, BISPECIFIC ANTIGEN-BINDING MOLECULES THAT BIND CD3 AND CD20, AND USES THEREOF

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/28
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
Andrew Bentham, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP14290019

Method for obtaining low ethanol-producing yeast strains, yeast strains obtained therefrom and their use

IPC classification:
C12G 1/022, C12N 1/16, C12N 1/36, C12P 1/02, C12R 1/865
Applicant:
Institut National de la Recherche Agronomique (INRA)
Agent:
Andrew Bentham, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14198318

Trangenic mice with a modified endogenous lambda immunoglobulin locus

IPC classification:
A01K 67/027, C07K 16/00, C07K 16/18, C07K 16/46, C12N 15/85
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
Andrew Bentham, J A Kemp
Status:
The patent has been granted
EP11713425

MAIZE ACC SYNTHASE 3 GENE AND PROTEIN AND USES THEREOF

IPC classification:
C12N 9/88, C12N 15/82
Applicant:
Pioneer Hi-Bred International Inc.
Applicant:
E. I. Du Pont de Nemours and Company
Agent:
Andrew Bentham, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13795943

ANTI-PROKINETICIN RECEPTOR (PROKR) ANTIBODIES AND USES THEREOF

IPC classification:
A61P 1/00, A61P 23/00, C07K 16/28
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13795965

METHODS OF TREATING OVARIAN CANCER WITH DLL4 ANTAGONISTS

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/22
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14781783

NON-HUMAN ANIMALS HAVING A HUMANIZED SIGNAL-REGULATORY PROTEIN GENE

IPC classification:
A01K 67/027, C07K 14/705, C12N 15/90
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
Andrew Bentham, J A Kemp
Status:
The patent has been granted
EP13812412

METHODS AND COMPOSITIONS FOR PRODUCING AND SELECTING TRANSGENIC PLANTS

IPC classification:
C12N 15/82
Applicant:
Pioneer Hi-Bred International Inc.
Agent:
Andrew Bentham, J A Kemp
Status:
APPLICATION WITHDRAWN
EP12716101

ADAM6 MICE

IPC classification:
A01K 67/027, C07K 16/28, C07K 16/40, C07K 16/46, C12N 9/64, C12N 15/85
Agent:
Martin Grund, Grund Intellectual Property Group
Agent:
EIP Europe LLP
Agent:
Andrew Bentham, J A Kemp
Status:
PATENT GRANTED
EP13865622

SYSTEMS AND METHODS FOR PLUG LOAD CONTROL AND MANAGEMENT

IPC classification:
G01R 11/56
Agent:
Andrew Bentham, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13821368

PROLACTIN RECEPTOR BINDING PROTEINS AND USES THEREOF

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/28
Applicant:
AbbVie Inc
Agent:
Micaela Modiano, Modiano & Partners
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP15168051

CORN EVENT TC1507 AND METHODS FOR DETECTION THEREOF

IPC classification:
C12N 15/82, C12Q 1/68
Applicant:
Dow AgroSciences LLC
Applicant:
Pioneer Hi-Bred International Inc.
Applicant:
E. I. Du Pont de Nemours and Company
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION REQUESTED
EP14735343

BIOLOGICAL SENSOR BASED SYSTEM FOR DETECTING MATERIALS

IPC classification:
A01K 15/00
Agent:
Andrew Bentham, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP11748969

TREATMENT

IPC classification:
A61K 31/00, A61K 38/04, A61P 1/16, A61P 13/12
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14701449

ANTI-PDGFR-beta ANTIBODIES AND USES THEREOF

IPC classification:
A61K 39/00, A61K 39/395, A61P 27/00, C07K 14/00, C07K 16/28
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14740843

ULTRASOUND-DETECTABLE MARKERS, ULTRASOUND SYSTEM, AND METHODS FOR MONITORING VASCULAR FLOW AND PATENCY

IPC classification:
A61B 8/00
Applicant:
Johns Hopkins University
Agent:
Andrew Bentham, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP14700770

DIAGNOSIS OF ULCERATIVE COLITIS

IPC classification:
G01N 33/574
Applicant:
UCL Business plc
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP15173007

BINDING PROTEINS COMPRISING VL DOMAINS

IPC classification:
A01K 67/027, C07K 16/00, C07K 16/08, C07K 16/46, C12N 15/85
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14704507

METHODS FOR INCREASING IMMUNOGLOBULIN A LEVELS

IPC classification:
A61P 29/00, A61P 31/00, C07K 16/24, C07K 16/28
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14746016

SYNTHETIC LIPOCHITOOLIGOSACCHARIDES FOR IMPROVEMENT OF PLANT GROWTH AND YIELD

IPC classification:
A61K 31/702
Applicant:
Pioneer Hi-Bred International Inc.
Applicant:
E. I. Du Pont de Nemours and Company
Agent:
Andrew Bentham, J A Kemp
Status:
APPLICATION WITHDRAWN
EP14706169

ANTIBODIES COMPRISING CHIMERIC CONSTANT DOMAINS

IPC classification:
C07K 16/28
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14737758

TEMPLATES, LIBRARIES, KITS AND METHODS FOR GENERATING MOLECULES

IPC classification:
C12P 19/34
Agent:
Andrew Bentham, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP14706210

MODIFIED GLYCOLIPIDS AND METHODS OF MAKING AND USING THE SAME

IPC classification:
A61K 31/7032, A61P 29/00, A61P 31/00, A61P 33/00, A61P 35/00, A61P 37/00, C07H 15/18
Applicant:
Albert Einstein College of Medicine Inc.
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION REQUESTED
EP14705679

B CELL LINEAGE BASED IMMUNOGEN DESIGN WITH HUMANIZED ANIMALS

IPC classification:
A01K 67/027, A61K 39/00, C07K 16/00
Applicant:
Regeneron Pharmaceuticals Inc
Applicant:
Duke University
Agent:
Andrew Bentham, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP14749671

CYTOLOGICAL STAINING COMPOSITIONS AND USES THEREOF

IPC classification:
A01N 37/52, G01N 1/30
Agent:
Andrew Bentham, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP14760590

IMMUNOTHERAPEUTIC POTENTIAL OF MODIFIED LIPOOLIGOSACCHARIDES/LIPID A

IPC classification:
A61K 39/00, A61K 39/02, C12P 19/00
Applicant:
University of Washington CoMotion
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION REQUESTED
EP14708775

HUMAN ANTIBODIES TO SERUM RESISTANCE-ASSOCIATED PROTEIN FROM TRYPANOSOMA BRUCEI RHODESIENSE

IPC classification:
C07K 16/18
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14714473

ENGAGER CELLS FOR IMMUNOTHERAPY

IPC classification:
A61K 35/14, C07K 16/28, C07K 16/46, C12N 5/0783
Applicant:
Celgene Corporation
Applicant:
Baylor College of Medicine
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14714474

HEPARANASE EXPRESSION IN HUMAN T LYMPHOCYTES

IPC classification:
A61K 35/14, A61K 39/00, C12N 5/0783
Applicant:
Baylor College of Medicine
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14714851

ONCOLYTIC VIRUS

IPC classification:
A61K 35/76, C07K 16/28, C07K 16/30
Applicant:
Baylor College of Medicine
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14722467

COMPOSITIONS HAVING DICAMBA DECARBOXYLASE ACTIVITY AND METHODS OF USE

IPC classification:
A01N 37/40, C07K 16/40, C12N 9/88, C12N 15/82
Applicant:
Pioneer Hi-Bred International Inc.
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14716506

COMPOSITIONS HAVING DICAMBA DECARBOXYLASE ACTIVITY AND METHODS OF USE

IPC classification:
C12N 15/82
Applicant:
Pioneer Hi-Bred International Inc.
Agent:
Andrew Bentham, J A Kemp
Status:
APPLICATION WITHDRAWN
EP14774677

ROOT-PREFERRED PROMOTER AND METHODS OF USE

IPC classification:
C12N 15/113
Applicant:
Pioneer Hi-Bred International Inc.
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION REQUESTED
EP14722458

APELIN FUSION PROTEINS AND USES THEREOF

IPC classification:
A61K 38/10, A61K 38/17, C07K 7/08, C07K 14/47
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14713709

HUMAN ANTIBODIES TO GREM 1

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/18
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION REQUESTED
EP14778140

IMPROVED MEDICAL DEVICE

IPC classification:
A61K 31/74, A61K 35/50, A61K 38/18, C12N 15/19
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION REQUESTED
EP14782569

Sept4/ARTS AS A TUMOR SUPPRESSOR IN THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF HEPATIC DISORDERS

IPC classification:
A61K 38/17, A61P 1/16, A61P 35/00, C12Q 1/68, G01N 33/574
Applicant:
The Rockefeller University
Applicant:
Carmel-Haifa University Economic Corp. Ltd.
Agent:
Andrew Bentham, J A Kemp
Agent:
Boult Wade Tennant Ltd
Status:
EXAMINATION REQUESTED
EP14778864

ROOT-PREFERRED PROMOTER AND METHODS OF USE

IPC classification:
A01H 5/00, C12N 15/82
Applicant:
Pioneer Hi-Bred International Inc.
Agent:
Andrew Bentham, J A Kemp
Status:
The patent has been granted
EP14727664

IMMUNOSUPPRESSIVE TGF-BETA SIGNAL CONVERTER

IPC classification:
C07K 14/71
Applicant:
Baylor College of Medicine
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14724967

METHODS FOR CHARACTERIZING DNA SEQUENCE COMPOSITION IN A GENOME

IPC classification:
C12Q 1/68
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14719826

P2X7 RECEPTOR AGONIST FOR USE IN PREVENTING OR TREATING KIDNEY INJURY

IPC classification:
A61K 31/7076, A61K 38/16, A61P 13/12, G01N 33/48
Applicant:
UCL Business plc
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION REQUESTED
EP15182056

AGONISTIC ANTI-CD40 ANTIBODIES

IPC classification:
A61K 39/12, C07K 16/28
Applicant:
Baylor Research Institute
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14797437

CHONDROADHERIN FRAGMENTS AS INDICATORS OF INTERVERTEBRAL DISC DEGENERATION

IPC classification:
C07K 5/107, C07K 7/06, C07K 14/47, C07K 14/78, C07K 16/18, C12P 21/06, C12Q 1/00, C12Q 1/37, G01N 33/48, G01N 33/53
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION REQUESTED
EP10801537

DIRECT AND CONTINUOUS ROOT ALONE OR ROOT/SHOOT PRODUCTION FROM TRANSGENIC EVENTS DERIVED FROM GREEN REGENERATIVE TISSUES AND ITS APPLICATIONS

IPC classification:
C12N 15/82
Agent:
Andrew Bentham, J A Kemp
Status:
APPLICATION WITHDRAWN
EP11701734

POLYNUCLEOTIDE AND POLYPEPTIDE SEQUENCES ASSOCIATED WITH HERBICIDE TOLERANCE

IPC classification:
A01H 5/00, C12N 15/11, C12Q 1/68
Agent:
Andrew Bentham, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14807846

RECOMBINANT MICROORGANISMS EXHIBITING INCREASED FLUX THROUGH A FERMENTATION PATHWAY

IPC classification:
C12P 7/04, C12P 7/06, C12P 7/16
Applicant:
Lanzatech New Zealand Limited
Agent:
Andrew Bentham, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP14739600

METHODS FOR TREATING AUTOSOMAL DOMINANT HYPERCHOLESTEROLEMIA ASSOCIATED WITH PCSK9 GAIN-OF-FUNCTION MUTATIONS

IPC classification:
A61K 39/00, C07K 16/40, C12Q 1/68
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION REQUESTED
EP14808354

LIPOSOMES FOR MODULATING WISKOTT-ALDRICH SYNDROME PROTEIN

IPC classification:
A61K 9/127, A61K 38/00, A61P 7/00, C12N 15/113, C12N 15/88
Applicant:
Bar-Ilan University (אוניברסיטת בר-אילן)
Agent:
Andrew Bentham, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP14811656

TARGETING TUMOR NEOVASCULATURE WITH MODIFIED CHIMERIC ANTIGEN RECEPTORS

IPC classification:
C07K 16/30
Applicant:
University of Houston System
Agent:
Andrew Bentham, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP14817259

DENDRITIC CELL ASGPR TARGETING IMMUNOTHERAPEUTICS FOR MULTIPLE SCLEROSIS

IPC classification:
A61K 39/00
Applicant:
Baylor Research Institute
Agent:
Andrew Bentham, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP14748058

METHOD OF ENHANCING POTENCY OF IMMUNE CELLS

IPC classification:
A61K 31/7068
Applicant:
Baylor College of Medicine
Agent:
Andrew Bentham, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP14750421

ANTI-ACTIVIN A ANTIBODIES AND USES THEREOF

IPC classification:
A61K 39/395, C07K 16/22
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
Andrew Bentham, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP15727106

HUMANIZED IL-4 AND IL-4R ALPHA ANIMALS

IPC classification:
A01K 67/027, C07K 14/54, C07K 14/715
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
Andrew Bentham, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP12192636

Methods for altering the genome of a monocot plant cell

IPC classification:
A01H 5/00, C12N 9/22, C12N 15/82
Applicant:
Pioneer Hi-Bred International Inc.
Agent:
Andrew Bentham, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11811459

VIRAL PROMOTER, TRUNCATIONS THEREOF, AND METHODS OF USE

IPC classification:
C12N 15/82
Applicant:
Pioneer Hi-Bred International Inc.
Applicant:
E. I. Du Pont de Nemours and Company
Agent:
Andrew Bentham, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14841529

GENE THERAPY FOR THE REGENERATION OF CHONDROCYTES OR CARTILAGE TYPE CELLS

IPC classification:
A61K 48/00
Agent:
Andrew Bentham, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP14844036

RECOMBINANT MICROORGANISMS AND METHODS OF USE THEREOF

IPC classification:
C12N 15/31, C12Q 1/68, G01N 33/53
Agent:
Andrew Bentham, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP14845503

A FERMENTATION PROCESS

IPC classification:
C12P 7/16, C12P 7/18
Agent:
Andrew Bentham, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP14851712

TM4SF1 BINDING PROTEINS AND METHODS OF USING SAME

IPC classification:
A61K 39/395, C07K 16/00, G01N 33/566
Applicant:
Beth Israel Deaconess Medical Center Inc
Agent:
Andrew Bentham, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP11812829

NOVEL BACTERIA AND METHODS OF USE THEREOF

IPC classification:
C12N 1/20, C12P 7/06, C12R 1/145
Applicant:
Lanzatech New Zealand Limited
Agent:
Andrew Bentham, J A Kemp
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14810088

APLNR MODULATORS AND USES THEREOF

IPC classification:
C07K 16/28
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION REQUESTED
EP14824545

PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF METASTATIC CANCER

IPC classification:
A61K 38/17, A61P 35/04
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION REQUESTED
EP14867101

MICROORGANISMS AND METHODS FOR THE PRODUCTION OF KETONES

IPC classification:
C12N 1/21, C12N 9/04, C12P 7/62
Applicant:
Lanzatech New Zealand Limited
Agent:
Andrew Bentham, J A Kemp
Status:
APPLICATION WITHDRAWN
EP14830734

REDUCTION OF INFLAMMATORY DISEASE SYMPTOMS BY SHORT PEPTIDES THAT INHIBIT SIGNALING THROUGH CD28

IPC classification:
A61K 38/17, C07K 14/705
Applicant:
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION REQUESTED
EP14833313

MARKERS FOR DISEASE RESISTANCE IN MAIZE

IPC classification:
C12Q 1/68
Agent:
Andrew Bentham, J A Kemp
Status:
APPLICATION WITHDRAWN
EP14831132

IMPROVED MOLECULAR BREEDING METHODS

IPC classification:
A01H 1/04, C12Q 1/68, G06F 19/12
Applicant:
Pioneer Hi-Bred International Inc.
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION REQUESTED
EP16159238

ANTI-CD40 ANTIBODIES AND USES THEREOF

IPC classification:
A61K 39/00, A61K 39/395, A61P 35/00, C07K 14/005, C07K 16/28, C07K 16/30, C07K 19/00, C12N 15/62, C12N 15/63
Applicant:
Baylor Research Institute
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION REQUESTED
EP10833897

IMMUNOMODULATORY COMPOUNDS FOR THE RESTORATION OF VITAMIN D SENSITIVITY IN VITAMIN D RESISTANT TUMOR CELLS

IPC classification:
A61K 31/45, A61K 31/454, A61K 31/593, G01N 33/50
Applicant:
Celgene Corporation
Agent:
Andrew Bentham, J A Kemp
Status:
PATENT GRANTED
EP11700212

IDENTIFICATION OF DIURNAL RHYTHMS IN PHOTOSYNTHETIC AND NON-PHOTOSYNTHETIC TISSUES FROM ZEA MAYS AND USE IN IMPROVING CROP PLANTS

IPC classification:
A01H 5/00, C07K 14/415, C12N 5/10, C12N 15/82
Applicant:
Pioneer Hi-Bred International Inc.
Applicant:
E. I. Du Pont de Nemours and Company
Agent:
Andrew Bentham, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11701933

METHODS OF TREATING AUTOIMMUNE DISEASES WITH DLL4 ANTAGONISTS

IPC classification:
A61K 39/395, A61P 37/00, C07K 16/22
Agent:
Andrew Bentham, J A Kemp
Status:
PATENT GRANTED
EP15735460

NOVEL VACCINES AGAINST HPV AND HPV-RELATED DISEASES

IPC classification:
A61K 39/12, A61K 39/395, C07K 16/08, C07K 16/28, C07K 16/46
Applicant:
Baylor Research Institute
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION REQUESTED
EP16177805

COMPOSITIONS AND METHODS TO CONTROL INSECT PESTS

IPC classification:
A01H 5/00, C12N 15/82
Applicant:
E. I. Du Pont de Nemours and Company
Agent:
Andrew Bentham, J A Kemp
Status:
Request for examination was made
EP15703380

HUMAN ANTIBODIES TO PD-L1

IPC classification:
A61K 39/00, A61K 39/395, A61P 35/00, C07K 16/22, C07K 16/28, C07K 16/30
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION REQUESTED
EP15703187

HUMAN ANTIBODIES TO PD-1

IPC classification:
C07K 16/28
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION REQUESTED
EP15742642

BACTERIUM WITH INCREASED TOLERANCE TO BUTYRIC ACIDS

IPC classification:
C12N 1/20, C12P 7/00
Applicant:
Lanzatech New Zealand Limited
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION REQUESTED
EP15702250

METHOD FOR OBTAINING LOW ETHANOL-PRODUCING YEAST STRAINS, YEAST STRAINS OBTAINED THEREFROM AND THEIR USE

IPC classification:
C12G 1/022, C12N 1/16, C12N 1/36, C12P 1/02, C12R 1/865
Applicant:
Institut National de la Recherche Agronomique (INRA)
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION REQUESTED
EP15742928

RECOMBINANT MICROORGANISMS AND METHODS OF USE THEREOF

IPC classification:
C12N 1/21, C12N 9/02
Applicant:
Lanzatech New Zealand Limited
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION REQUESTED
EP15743463

METHOD OF PRODUCING A RECOMBINANT MICROORGANISM

IPC classification:
C12N 1/15, C12N 1/21, C12N 7/01, C12N 15/63
Applicant:
Lanzatech New Zealand Limited
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION REQUESTED
EP15708059

INSECTICIDAL PROTEINS AND METHODS FOR THEIR USE

IPC classification:
C07K 14/415, C12N 15/82
Applicant:
Pioneer Hi-Bred International Inc.
Applicant:
E. I. Du Pont de Nemours and Company
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION REQUESTED
EP15705872

INSECTICIDAL PROTEINS AND METHODS FOR THEIR USE

IPC classification:
A01N 65/04, C07K 14/415, C12N 15/29, C12N 15/62, C12N 15/82
Applicant:
Pioneer Hi-Bred International Inc.
Applicant:
E. I. Du Pont de Nemours and Company
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION REQUESTED
EP15751948

BIOMARKER DIRECTED MULTI-TARGET IMMUNOTHERAPY

IPC classification:
A61K 39/00
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION REQUESTED
EP15714116

ANTIBODY COMPOSITIONS FOR TUMOR TREATMENT

IPC classification:
A61K 39/395, C07K 16/28
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION REQUESTED
EP15715085

FGF21 RECEPTOR AGONISTS AND USES THEREOF

IPC classification:
C07K 16/22, C07K 16/28
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION REQUESTED
EP15782800

RECOMBINANT LISTERIA VACCINE STRAINS AND METHODS OF PRODUCING THE SAME

IPC classification:
C12N 1/21
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION REQUESTED
EP15721089

SINGLE-CHAIN TRAIL-RECEPTOR AGONIST PROTEINS

IPC classification:
A61K 38/00, A61K 38/19, C07K 14/705
Applicant:
Apogenix AG
Applicant:
AbbVie Inc
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION REQUESTED
EP15710983

RAPID ACTING LACTOBACILLUS STRAINS AND THEIR USE TO IMPROVE AEROBIC STABILITY OF SILAGE

IPC classification:
C12N 1/22, C12R 1/225, C12R 1/24, A23K 30/18
Applicant:
Pioneer Hi-Bred International Inc.
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION REQUESTED
EP16189342

ANTIBODIES AGAINST CD40

IPC classification:
A61K 39/00, A61K 39/395, A61P 35/00, C07K 14/005, C07K 14/435, C07K 16/28, C07K 16/30, C07K 19/00, C12N 15/62, C12N 15/63
Applicant:
Baylor Research Institute
Agent:
Andrew Bentham, J A Kemp
Status:
Request for examination was made
EP15792154

METHODS AND COMPOSITIONS FOR TREATING AUTOIMMUNE AND INFLAMMATORY CONDITIONS

IPC classification:
A01N 63/00, A61K 38/20, A61K 39/00, A61K 39/395, A61P 19/02, A61P 29/00, C07K 19/00
Applicant:
Baylor Research Institute
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION REQUESTED
EP15803012

METHODS AND COMPOSITIONS FOR TREATING ALLERGY AND INFLAMMATORY DISEASES

IPC classification:
A61K 39/00, A61K 39/395, C07K 14/33, C07K 14/47, C07K 16/00, C07K 16/28
Applicant:
Baylor Research Institute
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION REQUESTED
EP15814509

PLANTS HAVING ENHANCED TOLERANCE TO INSECT PESTS AND RELATED CONSTRUCTS AND METHODS INVOLVING INSECT TOLERANCE GENES

IPC classification:
A01H 1/00, C12N 5/14, C12N 15/29, C12N 15/82
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION REQUESTED
EP15744975

BIOCONTROL OF SEED-ASSOCIATED DISEASES IN SEEDLINGS

IPC classification:
A01N 63/00, A01P 1/00, C12N 1/20
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION REQUESTED
EP15749891

A BIOCONTROL COMBINATION AND METHOD FOR IMPROVING QUALITY OF SHELLED EGGS

IPC classification:
A01K 45/00
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION REQUESTED
EP15738442

DIAGNOSTICS

IPC classification:
C12Q 1/26, G01N 33/50
Applicant:
UCL Business plc
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION REQUESTED
EP15822487

RECOMBINANT LISTERIA STRAIN EXPRESSING HETEROLOGOUS ANTIGEN FUSION PROTEINS AND METHODS OF USE THEREOF

IPC classification:
A61K 35/74, A61K 39/02, A61K 39/12, A61P 35/00
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION REQUESTED
EP15821743

LISTERIA-BASED IMMUNOGENIC COMPOSITIONS FOR ELICITING ANTI-TUMOR RESPONSES

IPC classification:
A61K 35/74, A61K 39/02, A61K 39/12, A61P 35/00
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION REQUESTED
EP15757027

PLANT REGULATORY ELEMENTS AND METHODS OF USE THEREOF

IPC classification:
C12N 15/82
Applicant:
Pioneer Hi-Bred International Inc.
Applicant:
E. I. Du Pont de Nemours and Company
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION REQUESTED
EP15831619

GENETICALLY ENGINEERED BACTERIUM WITH ALTERED CARBON MONOXIDE DEHYDROGENASE (CODH) ACTIVITY

IPC classification:
C12N 1/21, C12N 9/02, C12N 15/63, C12P 7/06, C12P 7/08, C12P 7/18
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION REQUESTED
EP15753512

METHODS AND DEVICES INVOLVING OIL MATRICES

IPC classification:
C12Q 1/68
Applicant:
Pioneer Hi-Bred International Inc.
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION REQUESTED
EP15753218

SYSTEMS AND METHODS FOR PERICARP GENOTYPING

IPC classification:
C12Q 1/68
Applicant:
Pioneer Hi-Bred International Inc.
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION REQUESTED
EP15729707

SYSTEMS AND METHODS FOR GENOTYPING PLANT MATERIAL

IPC classification:
C12Q 1/68
Applicant:
Pioneer Hi-Bred International Inc.
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION REQUESTED
EP15835663

SOYBEAN EXTRACTS AND COMBINATIONS THEREOF WITH POLYETHOXYLATED CASTOR OIL AND OTHER ADJUVANTS FOR CONTROLING BLOOD SUGAR LEVELS AND FOR HEPATOPROTECTION

IPC classification:
A61K 9/08, A61K 31/66, A61K 31/685, A61K 36/48
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION REQUESTED
EP15730602

PLANT EMBRYO STORAGE AND MANIPULATION

IPC classification:
A01H 4/00, A01N 3/00, C12N 5/00, C12N 5/04, C12Q 1/68
Applicant:
Pioneer Hi-Bred International Inc.
Agent:
Andrew Bentham, J A Kemp
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature